Top Stories
Social media anxiety order
Phil Baumann outlines why the pharma industry needs to submerge itself into the binary world of social media.
Read more
The eye of the social storm
As the social media revolution continues its surge of success in the realms of digital marketing and communications, Nick Pryke takes a look at why sailing into the eye of its storm could be the best thing for the pharma...
Read more
Casting a wider net
How Eli Lilly’s towards a networking structure could serve them well at the innovation table.
Read more
H1N1 pandemic: 'unjustified scare' and was...
The handling of the H1N1 pandemic by the World Health Organization (WHO), along with European Union agencies and national governments, resulted in a "waste of large sums of public money, and unjustified scares and fears...
Read more
The emerging pharmaceutical markets
Emerging markets look set to catch up to the Western world in healthcare standards. Jesper Høiland outlines the pharmaceutical industry’s response.
Read more